Tunatar da ni. The Immunization Reminder and Information SMS System (IRISS)
NCT04001322 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2022-10-07
Summary
In 2016, only 33% of Nigerian children aged 12-23 months had been vaccinated with the 3rd dose of the pentavalent vaccine. Lack of knowledge was the leading reason for non-vaccination. To overcome this knowledge gap, this project, "Tunatar da ni", will deliver targeted text messages to community leaders and individualized text messages to parents and caregivers in Kebbi state, Northwest Nigeria, a state with very low coverage of immunization (19% penta 3 coverage in 2018).
These text messages, also known as Short Messaging System (SMS) messages will be managed, scheduled and sent from a purpose-built, cloud-based Immunization Reminder and Information SMS System (IRISS). The messages will be deployed in three ways, as:
1. General broadcast of messages on the importance of immunization to all active mobile phone subscribers in the intervention area.
2. Targeted educational, informational, normative and motivational messages on immunization, and reminders on the local immunization clinic schedules, to community members who voluntarily registered into IRISS for these messages, and to traditional and religious leaders who then share these information with their communities.
3. Individualized reminders of a child's immunization due dates and local clinic schedule to parents who voluntarily registered their child's information on IRISS in order to receive these reminders.
Study investigators hypothesize that providing community leaders with positive and actionable messages on immunization services will improve their understanding of the value of vaccines and provide them facts to drive discussions, build positive norms and increase acceptance of vaccination. Providing targeted reminders to parents about their child's vaccination due date and the schedule of their local vaccination clinics will motivate their timely action to seek vaccination services for their children.
Intervention will be evaluated using a two-arm cluster randomized controlled trial design. All 21 Local Government Areas (LGAs) in Kebbi state will be involved. Based on a 2:1 ratio, 14 LGAs will be randomly assigned to receive the SMS intervention while 7 LGAs will serve as controls.
The primary outcome measure will be the proportion of children aged 0-11 months who are appropriately vaccinated for age. The data to compare this outcome between the intervention and control arms, will be obtained from the quarterly lot quality assurance surveys done by the Nigerian government.
Conditions
- Low Immunization Uptake
Interventions
- OTHER
-
Community engagement
The government will conduct a cascade of sensitization meetings with traditional leaders at all levels to promote newborn line listing (birth registration), reconciliation of child's vaccination status and defaulter tracking (home-based follow up of children who have missed their vaccination doses) by health providers and community leaders
- OTHER
-
IRISS advert for opt-in
A module to advertise and demonstrate how individuals can opt-in to IRISS to receive the messages will be included in the community engagement sensitization meetings.
- OTHER
-
One-time SMS broadcast on immunization
General broadcast of SMS messages on the importance of immunization to all active mobile phone subscribers in the intervention LGAs
- OTHER
-
Scheduled weekly SMS reminder of health facility RI schedule to community leaders
Traditional and religious leaders who have a phone or access to a phone and have been registered on IRISS will receive SMS messages on the immunization session schedule of the health facilities in their communities, so they can disseminated the information through their town announcers to inform parents and caregivers. For example, "Ribah clinic is holding a vaccination session tomorrow from 8am to 2pm. Please take your child there to vaccinate them and encourage your neighbors to vaccinate their children."
- OTHER
-
Scheduled bi weekly RI messages to community leaders
Traditional and religious leaders who own or have access to a phone and have been registered on IRISS will receive SMS messages on immunization, to share same with community members. The message categories are: 1) Educational messages that provide facts and increase knowledge, e.g. "Have you heard of Penta vaccine? It protects against 5 diseases: they are diphtheria, whooping cough, tetanus, HiB and Hepatitis B." 2) Informative messages that dispel myths about immunization, e.g. "Getting more than one vaccine at the same time does not harm a child. It is very important to completely receive all vaccine doses for full protection." 3) Normative messages to promote positive norms, e.g. "Our religious leaders have immunized their children, what are we waiting for"? 4) Motivational messages to inspire action, e.g. "Each visit to the health center for vaccination will reap many health benefits. Say YES to good health, be on time and complete your child's vaccination."
- OTHER
-
Responsive individualized child vaccination schedule reminder to caregivers who opt-in
Parents and caregivers who voluntarily registered their child's information into IRISS will receive a reminder, a day before, about their child's due vaccines and the schedule of vaccination sessions in the health facilities within their locality (wards), e.g. "Greetings! Amina is due for Penta 1 tomorrow, kindly visit Ribah clinic. They vaccinate on Mondays and Thursdays."
- OTHER
-
Responsive one-time SMS message on hand washing to those that erroneously register on IRISS
If individuals from control LGAs encounter IRISS adverts inadvertently and erroneously register into IRISS expecting a message, to avoid a loss in trust if no message is sent, they will receive a one-time general message about the importance of hand-washing, e.g. "Wash your hand with soap and water every time you finish from to the toilet, to maintain clean hands and avoid germs that make you sick."
Sponsors & Collaborators
-
Bill and Melinda Gates Foundation
collaborator OTHER -
Direct Consulting and Logistics
collaborator UNKNOWN -
Johns Hopkins Bloomberg School of Public Health
lead OTHER
Principal Investigators
-
Chizoba B Wonodi, MD,MPH,DrPH · Johns Hopkins Bloomberg School of Public Health
-
Alain Labrique, MD,MHS,PHD · Johns Hopkins Bloomberg School of Public Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-06-15
- Primary Completion
- 2020-10-30
- Completion
- 2020-11-29
Countries
- Nigeria
Study Locations
More Related Trials
-
Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
NCT02118961 ·Status: COMPLETED ·Phase: PHASE3
-
Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957 ·Status: COMPLETED ·Phase: NA
-
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
NCT01529645 ·Status: COMPLETED ·Phase: PHASE1
-
Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants
NCT03589768 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT00715234 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
NCT00467519 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
NCT05091619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
NCT03000998 ·Status: COMPLETED ·Phase: NA
-
Effects of Buzzy® and ShotBlocker® on Pain, Anxiety and Satisfaction During the Administration of Vaccine
NCT06397352 ·Status: COMPLETED ·Phase: NA
-
Safety Profile Following Td Vaccination in Indonesian Pregnant Woman
NCT03383653 ·Status: COMPLETED
-
Adolescent Vaccination Reminder Study
NCT01732315 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT )
NCT05870631 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
NCT02813486 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine
NCT00452686 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children
NCT05870618 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
Maternal Tdap Immunization in Guatemala
NCT02301702 ·Status: COMPLETED ·Phase: PHASE2
-
Tdap Vaccination for Infant Caregivers
NCT01233401 ·Status: COMPLETED
-
Study of Adolescent Immunization Recall Systems
NCT01390363 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Booster Dose Reminder/Recall for Adolescents
NCT05571657 ·Status: UNKNOWN ·Phase: NA
-
A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
NCT06997627 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Adolescent Vaccination Kiosk Project
NCT01622608 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children
NCT04618939 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.
NCT00406562 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
NCT01362322 ·Status: COMPLETED ·Phase: PHASE4